| 000 | 01736 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513235111.0 | ||
| 264 | 0 | _c20010705 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi0028800 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, L | |
| 245 | 0 | 0 |
_aBiochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides. _h[electronic resource] |
| 260 |
_bBiochemistry _cApr 2001 |
||
| 300 |
_a5049-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xenzymology |
| 650 | 0 | 4 | _aAmyloid Precursor Protein Secretases |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAspartic Acid Endopeptidases |
| 650 | 0 | 4 |
_aBrefeldin A _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane _xenzymology |
| 650 | 0 | 4 | _aCell-Free System |
| 650 | 0 | 4 |
_aEndopeptidases _xchemistry |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aLeupeptins _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Transport _xdrug effects |
| 650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aSong, L | |
| 700 | 1 | _aTerracina, G | |
| 700 | 1 | _aLiu, Y | |
| 700 | 1 | _aPramanik, B | |
| 700 | 1 | _aParker, E | |
| 773 | 0 |
_tBiochemistry _gvol. 40 _gno. 16 _gp. 5049-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi0028800 _zAvailable from publisher's website |
| 999 |
_c11240725 _d11240725 |
||